Related Experiment Videos
Summary
A novel mitochondrial creatine kinase (CK) isoenzyme in serum was detected in critically ill patients. Its presence indicates severe tissue damage and is associated with a poor prognosis, as many patients died shortly after detection.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Pathophysiology
Background:
- Creatine kinase (CK) is an enzyme crucial for cellular energy homeostasis.
- CK exists in different isoenzyme forms, including MM, MB, and mitochondrial CK (MtCK).
- Elevated serum CK levels are indicative of muscle damage, but specific isoenzyme analysis can provide further diagnostic information.
Purpose of the Study:
- To investigate the presence and significance of a specific CK isoenzyme band in patients experiencing shock.
- To determine the clinical implications and diagnostic value of this unusual CK isoenzyme in critical illness.
Main Methods:
- Serum samples were analyzed for creatine kinase (CK) isoenzyme patterns using electrophoresis.
- Patients presenting with shock were specifically monitored for the presence of a CK isoenzyme band cathodic to MM.
Main Results:
- A distinct CK isoenzyme band, migrating cathodically to the MM band and presumed to be mitochondrial CK (MtCK), was identified in eight patients in shock.
- Six out of these eight patients (75%) experienced fatal outcomes within 12 days of the isoenzyme detection.
- The detection of this MtCK isoenzyme in serum correlated with severe tissue damage.
Conclusions:
- The presence of a serum CK isoenzyme band cathodic to MM (likely MtCK) is a significant indicator in patients with shock.
- Severe tissue damage is a prerequisite for the release of this specific mitochondrial CK isoenzyme into the bloodstream at detectable levels.
- This finding suggests that serum MtCK may serve as a prognostic biomarker for severe tissue injury and mortality in critically ill patients.